<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016180"><a href="http://purl.obolibrary.org/obo/MONDO_0016180">MONDO:0016180</a></h3>
<p><strong>Label:</strong> hematological disease associated with an acquired peripheral neuropathy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019438">MONDO:0019438</a> (AL amyloidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0016138">MONDO:0016138</a> (malignant lymphoma with peripheral neuropathy), <a href="http://purl.obolibrary.org/obo/MONDO_0009693">MONDO:0009693</a> (multiple myeloma), <a href="http://purl.obolibrary.org/obo/MONDO_0007926">MONDO:0007926</a> (Waldenstrom macroglobulinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005615">MONDO:0005615</a> (plasmacytoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_207046">Orphanet:207046</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610430">OMIM:610430</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33226">Orphanet:33226</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254500">OMIM:254500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_29073">Orphanet:29073</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314701">Orphanet:314701</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86855">Orphanet:86855</a>, <a href="http://purl.obolibrary.org/obo/OMIM_153600">OMIM:153600</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85443">Orphanet:85443</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0005508">HP:0005508</a> (Monoclonal immunoglobulin M proteinemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0031047">HP:0031047</a> (Paraproteinemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0010702">HP:0010702</a> (Increased antibody level in blood) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005508">HP:0005508</a> (Monoclonal immunoglobulin M proteinemia) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005508">HP:0005508</a> (Monoclonal immunoglobulin M proteinemia) and <a href="http://purl.obolibrary.org/obo/HP_0009830">HP:0009830</a> (Peripheral neuropathy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000759">HP:0000759</a> (Abnormal peripheral nervous system morphology) and <a href="http://purl.obolibrary.org/obo/HP_0005508">HP:0005508</a> (Monoclonal immunoglobulin M proteinemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0005508">HP:0005508</a> (Monoclonal immunoglobulin M proteinemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) and <a href="http://purl.obolibrary.org/obo/HP_0031047">HP:0031047</a> (Paraproteinemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0011017">HP:0011017</a> (Abnormality of cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0010702">HP:0010702</a> (Increased antibody level in blood) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0009830">HP:0009830</a> (Peripheral neuropathy) and <a href="http://purl.obolibrary.org/obo/HP_0031047">HP:0031047</a> (Paraproteinemia) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0009830">HP:0009830</a> (Peripheral neuropathy) and <a href="http://purl.obolibrary.org/obo/HP_0011017">HP:0011017</a> (Abnormality of cell physiology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0009830">HP:0009830</a> (Peripheral neuropathy) and <a href="http://purl.obolibrary.org/obo/HP_0010702">HP:0010702</a> (Increased antibody level in blood) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005523">HP:0005523</a> (Lymphoproliferative disorder) and <a href="http://purl.obolibrary.org/obo/HP_0009830">HP:0009830</a> (Peripheral neuropathy) and <a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) 66.67%</li>
</ul>
</body>
</html>
